CL2008002310A1 - Compuestos derivados de benzoil-piperidinas, moduladores del receptor de dopamina d3 y de serotonina 5-ht2a; y uso en el tratamiento y/o prevencion de enfermedades tales como trastornos cognitivos, adiccion a farmacos, depresion y ansiedad. - Google Patents
Compuestos derivados de benzoil-piperidinas, moduladores del receptor de dopamina d3 y de serotonina 5-ht2a; y uso en el tratamiento y/o prevencion de enfermedades tales como trastornos cognitivos, adiccion a farmacos, depresion y ansiedad.Info
- Publication number
- CL2008002310A1 CL2008002310A1 CL2008002310A CL2008002310A CL2008002310A1 CL 2008002310 A1 CL2008002310 A1 CL 2008002310A1 CL 2008002310 A CL2008002310 A CL 2008002310A CL 2008002310 A CL2008002310 A CL 2008002310A CL 2008002310 A1 CL2008002310 A1 CL 2008002310A1
- Authority
- CL
- Chile
- Prior art keywords
- ht2a
- serotonin
- dopamine
- anxiety
- depression
- Prior art date
Links
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 title abstract 8
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 229940076279 serotonin Drugs 0.000 title abstract 3
- 208000019901 Anxiety disease Diseases 0.000 title abstract 2
- 230000036506 anxiety Effects 0.000 title abstract 2
- 206010013663 drug dependence Diseases 0.000 title abstract 2
- 208000011117 substance-related disease Diseases 0.000 title abstract 2
- YXTROGRGRSPWKL-UHFFFAOYSA-N 1-benzoylpiperidine Chemical class C=1C=CC=CC=1C(=O)N1CCCCC1 YXTROGRGRSPWKL-UHFFFAOYSA-N 0.000 title 1
- 102000004073 Dopamine D3 Receptors Human genes 0.000 title 1
- 108090000525 Dopamine D3 Receptors Proteins 0.000 title 1
- 208000010877 cognitive disease Diseases 0.000 title 1
- 230000006806 disease prevention Effects 0.000 title 1
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 4
- 102100036321 5-hydroxytryptamine receptor 2A Human genes 0.000 abstract 2
- 101710138091 5-hydroxytryptamine receptor 2A Proteins 0.000 abstract 2
- 229960003638 dopamine Drugs 0.000 abstract 2
- 102000005962 receptors Human genes 0.000 abstract 2
- 108020003175 receptors Proteins 0.000 abstract 2
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000009977 dual effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE LA FORMULA GENERAL (I) EN LA QUE R1 Y A TIENEN LOS SIGNIFICADOS DEFINIDOS EN LA DESCRIPCIÓN, COMO MODULADORES DUALES DE LOS RECEPTORES DE LA SEROTONINA 5-HT2A Y DE LA DOPAMINA D3, SU OBTENCIÓN, LAS COTNPOSJC¡I9NES FARMACÉUTICAS QUE LOS CONTIENEN Y SU UTILIZACIÓN COMO MEDICAMENTOS. LOS COMPUESTOS DE GENERAL FORMULA (I) TIENEN UNA GRAN AFINIDAD CON LOS RECEPTORES DE LA DOPAMINA D3 Y DE LA SEROTONINA (5-HIDROXITRIPTAMLNA; 5-HT) 5-HT2A Y SON EFICACES PARA EL TRATAMIENTO DE TRASTORNOS PSICÓTICOS, ASI COMO OTROS TRASTORNOS, TALES COMO LA DEPRESIÓN Y LA ANSIEDAD, LA DEPENDENCIA DE FÁRMACOS, LAS DEMENCIAS Y LOS DESEQUILIBRIOS DE MEMORIA.<br />
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07114119 | 2007-08-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2008002310A1 true CL2008002310A1 (es) | 2009-05-29 |
Family
ID=39865594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2008002310A CL2008002310A1 (es) | 2007-08-09 | 2008-08-06 | Compuestos derivados de benzoil-piperidinas, moduladores del receptor de dopamina d3 y de serotonina 5-ht2a; y uso en el tratamiento y/o prevencion de enfermedades tales como trastornos cognitivos, adiccion a farmacos, depresion y ansiedad. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8097637B2 (es) |
| EP (1) | EP2185513B1 (es) |
| JP (1) | JP5296073B2 (es) |
| KR (1) | KR101171467B1 (es) |
| CN (1) | CN101778820B (es) |
| AR (1) | AR067873A1 (es) |
| AT (1) | ATE512137T1 (es) |
| AU (1) | AU2008285729B2 (es) |
| BR (1) | BRPI0814999A2 (es) |
| CA (1) | CA2694057A1 (es) |
| CL (1) | CL2008002310A1 (es) |
| ES (1) | ES2366766T3 (es) |
| MX (1) | MX2010001195A (es) |
| PE (1) | PE20090513A1 (es) |
| TW (1) | TW200914422A (es) |
| WO (1) | WO2009019174A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2399447T3 (es) | 2006-02-17 | 2013-04-01 | F. Hoffmann-La Roche Ag | Derivados benzoil-piperidina como moduladores de 5HT2/D3 |
| RU2480466C2 (ru) * | 2007-07-26 | 2013-04-27 | Ф.Хоффманн-Ля Рош Аг | Двойные модуляторы 5-ht2a и d3-рецепторов |
| US8586579B2 (en) | 2010-06-21 | 2013-11-19 | Hoffmann-La Roche Inc. | Anellated pyridine compounds |
| US8470828B2 (en) | 2010-07-06 | 2013-06-25 | Hoffmann-La Roche Inc. | Anellated pyridine compounds |
| US8921397B2 (en) * | 2011-05-04 | 2014-12-30 | Hoffmann-La Roche Inc. | Benzofurane-piperidine compounds |
| WO2013086266A2 (en) * | 2011-12-08 | 2013-06-13 | The Board Of Regents Of The University Of Texas System | Allosteric modulators of 5-hydroxytryptamine 2c receptor (5-ht2cr) |
| HRP20200584T1 (hr) | 2014-12-12 | 2020-07-10 | Japan Tobacco Inc. | Spojevi dihidropirimidin-2-ona i njihova upotreba u medicini |
| CN117550989B (zh) * | 2023-11-14 | 2024-09-27 | 泰州精英化成医药科技有限公司 | 一种反式-2-(4-氨基环己基)乙酸乙酯盐酸盐的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2717479B1 (fr) * | 1994-03-18 | 1996-06-07 | Pf Medicament | Nouvelles 3-(omega-benzoylpipéridino) alcoyl)-4H-Benzopyran-4-ones, leur préparation et leur application en thérapeutique. |
| HUP0103986A2 (hu) * | 2001-09-28 | 2003-06-28 | Richter Gedeon Vegyészeti Gyár Rt. | Új karbonsavamid szerkezetet tartalmazó piperidinil vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények |
| HU227543B1 (en) * | 2001-09-28 | 2011-08-29 | Richter Gedeon Nyrt | N-[4-(2-piperazin- and 2-piperidin-1-yl-ethyl)-cyclohexyl]-sulfon- and sulfamides, process for their preparation, their use and pharmaceutical compositions containing them |
| AU2002366766A1 (en) * | 2001-12-13 | 2003-07-09 | Sumitomo Pharmaceuticals Co., Ltd. | Serotonine reuptake inhibitor |
| ES2399447T3 (es) * | 2006-02-17 | 2013-04-01 | F. Hoffmann-La Roche Ag | Derivados benzoil-piperidina como moduladores de 5HT2/D3 |
-
2008
- 2008-07-30 ES ES08786606T patent/ES2366766T3/es active Active
- 2008-07-30 WO PCT/EP2008/059971 patent/WO2009019174A1/en not_active Ceased
- 2008-07-30 KR KR1020107002763A patent/KR101171467B1/ko not_active Expired - Fee Related
- 2008-07-30 CA CA2694057A patent/CA2694057A1/en not_active Abandoned
- 2008-07-30 BR BRPI0814999-2A2A patent/BRPI0814999A2/pt not_active Application Discontinuation
- 2008-07-30 MX MX2010001195A patent/MX2010001195A/es active IP Right Grant
- 2008-07-30 JP JP2010519432A patent/JP5296073B2/ja not_active Expired - Fee Related
- 2008-07-30 AU AU2008285729A patent/AU2008285729B2/en not_active Ceased
- 2008-07-30 EP EP08786606A patent/EP2185513B1/en not_active Not-in-force
- 2008-07-30 AT AT08786606T patent/ATE512137T1/de active
- 2008-07-30 CN CN2008801026707A patent/CN101778820B/zh not_active Expired - Fee Related
- 2008-08-01 US US12/184,272 patent/US8097637B2/en not_active Expired - Fee Related
- 2008-08-06 CL CL2008002310A patent/CL2008002310A1/es unknown
- 2008-08-07 AR ARP080103450A patent/AR067873A1/es unknown
- 2008-08-07 PE PE2008001318A patent/PE20090513A1/es not_active Application Discontinuation
- 2008-08-08 TW TW097130407A patent/TW200914422A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE512137T1 (de) | 2011-06-15 |
| AR067873A1 (es) | 2009-10-28 |
| AU2008285729A1 (en) | 2009-02-12 |
| BRPI0814999A2 (pt) | 2015-02-03 |
| CN101778820B (zh) | 2012-12-05 |
| PE20090513A1 (es) | 2009-04-29 |
| EP2185513A1 (en) | 2010-05-19 |
| MX2010001195A (es) | 2010-03-01 |
| US20090042943A1 (en) | 2009-02-12 |
| CN101778820A (zh) | 2010-07-14 |
| EP2185513B1 (en) | 2011-06-08 |
| JP2010535735A (ja) | 2010-11-25 |
| CA2694057A1 (en) | 2009-02-12 |
| WO2009019174A1 (en) | 2009-02-12 |
| US8097637B2 (en) | 2012-01-17 |
| AU2008285729B2 (en) | 2012-11-01 |
| TW200914422A (en) | 2009-04-01 |
| ES2366766T3 (es) | 2011-10-25 |
| JP5296073B2 (ja) | 2013-09-25 |
| KR101171467B1 (ko) | 2012-08-07 |
| KR20100029850A (ko) | 2010-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2008002310A1 (es) | Compuestos derivados de benzoil-piperidinas, moduladores del receptor de dopamina d3 y de serotonina 5-ht2a; y uso en el tratamiento y/o prevencion de enfermedades tales como trastornos cognitivos, adiccion a farmacos, depresion y ansiedad. | |
| CR10872A (es) | Compuestos agonistas y antagonistas del receptor de esfingosina-1-fosfato | |
| CL2007000396A1 (es) | Compuestos derivados de benzoil-piperidina, moduladores del receptor 5ht2/d3; composicion farmaceutica que los comprende;y su uso en el tratamiento y/o prevencion de patologias delsnc, tales como psicosis, esquizofrenia, depresion, ansiedad,adiccion a drogas y problemas cognitivos. | |
| WO2009013212A3 (en) | Dual modulators of 5-ht2a and d3 receptors | |
| GT201000153A (es) | Agonistas novedosos de los receptores de glucocorticoides | |
| CL2008002864A1 (es) | Compuestos derivados de 2-amino-quinolina, antagonistas del receptor de serotonina 5-ht 5a; procedimiento de preparacion;composicion farmaceutica; y uso de los compuestos en la prevencion o el tratamiento de depresion,trastornos de ansiedad,esquizofrenia,trastornos de panico,trastornos de memoria,demencia,entre otros. | |
| ECSP10010533A (es) | Derivados de 4-aminociclohexano sustituido | |
| HN2010001563A (es) | Compuestos | |
| CL2011001263A1 (es) | Compuestos derivados de pirimidinonas opcionalmente sustituidas; composicion farmaceutica que los comprende; y su uso como inhibidores de fosfodiesterasa 1 (pde1) para el tratamiento de enfermedades que involucran trastornos de la trayectoria intracelular del receptor de dopamina d1 como parkinson, alzheimer, depresion, enfermedad bipolar, hipertension, glaucoma. | |
| NI201100084A (es) | Antagonistas del receptor de orexina de isonicotinamida. | |
| EA201100161A1 (ru) | Производные хинуклидина карбоната и их медицинские композиции | |
| SV2006002098A (es) | Compuestos de morfolina sustituida para el tratamiento de trastornos del sistema nervioso central ref. pc32250a | |
| EA201101709A1 (ru) | Полициклические антагонисты рецепторов лизофосфатидной кислоты | |
| CL2009000161A1 (es) | Compuestos derivados de 2,3,4,5-tetrahidro-1h-pirido[4,3-b]indol; composicion farmaceutica que los comprende; uso en el tratamiento de trastornos neurodegenerativos, cognitivos o psicoticos, enfermedad de alzheimer, entre otros; y un kit que contiene a los compuestos. | |
| UY32926A (es) | Compuestos como antagonistas de los receptores de ácido lisofosfatídico | |
| NI201500106A (es) | Derivados de benzotiofeno y composiciones de los mismos como degradantes selectivos de los receptores de estrógeno. | |
| UY30572A1 (es) | N-(1-ftalazin-1-il-piperidin-4-il)-amidas como moduladores del receptor ep2 | |
| CR11264A (es) | Compuestos de 5-(4-halo-alcoxi)-fenil)-pirimidin-2-amina y composiciones como inhibidores de cinasa | |
| EA201590873A1 (ru) | Соединения, обладающие активностью антагонистов мускариновых рецепторов и агонистов бета2 адренергических рецепторов | |
| EA201190017A1 (ru) | Аминоэфирные производные алкалоидов и их медицинские композиции | |
| CR9814A (es) | Derivados de carboxamida como antagonistas del receptor muscarinico | |
| CL2008002450A1 (es) | Compuestos derivados de fenil-pirrolidin-eter, con actividad antagonista de los receptores nk3; procedimientos para su preparacion; composicion farmaceutica; y el uso de los compuestos en el tratamiento de depresion, dolor, psicosis, entre otras. | |
| CY1113759T1 (el) | Ταχεως διασπομενοι ανταγωνιστες υποδοχεα ντοπαμινης 2 | |
| CR20130056A (es) | Derivados heterocíclicos fusionados como moduladores s1p | |
| EA201500651A1 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ ЦИКЛОГЕКСИЛ- И ХИНУКЛИДИНИЛКАРБАМАТА, ОБЛАДАЮЩИЕ АГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К β2 АДРЕНЕРГИЧЕСКОМУ РЕЦЕПТОРУ И АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К МУСКАРИНОВОМУ РЕЦЕПТОРУ М3 |